Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 10:09:50 2024-06-03 EDT 		5-day change 1st Jan Change
0.92 EUR +0.33% Intraday chart for Lavipharm S.A. -3.16% +15.58%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI
da2f8e96f15672b9ac6b94b733e68bd.Hm_J1HL_Y7J6JEKIp48XJhFtroZL-YuX0-J_PLoQwTA.dSSOmBS6POUcbTPAz9VzY3w-wOE5qbLFjKpGBM1nswJYFvyGGb0V1EoRdg~a241b6cd4da6a4bfa08dd914f87292ad
  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. Charts Lavipharm S.A.
  5. News Chart